VIP (Human, Rat, Mouse, Porcine, Ovine) - RIA Kit


Catalog #
RK-064-16 125 tubes $776

  • Protocol:
  • View/Download (PDF) - for reference only
  • Sample Preparation:
  • Suggested Procedure
  • Sample Extraction:
  • Recommended
  • Sensitivity: polaroid
    Data may differ slightly based on lot.
  • 49.2 pg/ml
  • Standard Range:
  • 10 - 1280 pg/ml
  • Cross Reactivity:
  • Peptide %
    VIP (Human, Porcine, Rat) 100
    PACAP-27-NH2 (Human, Rat, Ovine) 0
    PHM-27 (Human) 0
    Substance P 0
    (Human, Rat, Porcine, Mouse, Canine, Bovine)
    Glucagon (Human) 0
    Galanin (Rat) 0
    Somatostatin 0
    PACAP-38 (Human, Rat, Ovine) 0

  • Radioactivity:
  • Each kit contains 1.5 µCi of Iodine 125.
  • Disclaimer:
  • This package conforms to the 49 CFR173.421 for expected radioactive material limited quantity, N.O.S. UN2910.

Kuncová J, Chvojka J, Sýkora R, et al. Tissue concentrations of vasoactive intestinal peptide are affected by peritonitis-induced sepsis and hemofiltration in pigs.
Physiol Res. 2011;60(3):531-40.

Hook et al. Differential activation of enkephalin, galanin, somatostatin, NPY, and VIP neuropeptide production by stimulators of protein kinases A and C in neuroendocrine chromaffin cells.
Neuropeptides. 2008 Oct-Dec;42(5-6):503-11.

Hong et al. Role of vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide in the vaginal wall of women with stress urinary incontinence and pelvic organ prolapse.
Int Urogynecol J Pelvic Floor Dysfunct. 2008 Aug;19(8):1151-7.

Kuncová et al. Chronic atropine administration diminishes the contribution of vasoactive intestinal polypeptide to heart rate regulation.
Physiol Res. 2007 Nov 30. [Epub ahead of print]

Huang et al. Differential signaling of T cell generation of IL-4 by wild-type and short-deletion variant of type 2 G protein-coupled receptor for vasoactive intestinal peptide (VPAC2).
J Immunol. 2006 Jun 1;176(11):6640-6.

Caviedes-Bucheli et al. Quantification of neuropeptides (calcitonin gene-related peptide, substance P, neurokinin A, neuropeptide Y and vasoactive intestinal polypeptide) expressed in healthy and inflamed human dental pulp.
Int Endod J. 2006 May;39(5):394-400.

Dvoráková et al. Down-regulation of vasoactive intestinal peptide and altered expression of its receptors in rat diabetic cardiomyopathy.
Cell Tissue Res. 2006 Mar;323(3):383-93.

Kuncová et al. Distribution of vasoactive intestinal polypeptide in the rat heart: effect of guanethidine and capsaicin.
Ann Anat. 2003 Apr;185(2):153-61.

Voice et al. Roles of Vasoactive Intestinal Peptide (VIP) in the Expression of Different Immune Phenotypes by Wild-Type Mice and T Cell-Targeted Type II VIP Receptor Transgenic Mice.
J Immunol. 2003 Jan 1;170(1):308-14.

Mazzacchi et al. Expression and function of vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and their receptors in the human adrenal gland.
J Clin Endocrinol Metab. 2002 Jun;87(6):2575-80.

Netzer et al. Does intravenous ondansetron affect gastric emptying of a solid meal, gastric electrical activity or blood hormone levels in healthy volunteers?
Aliment Pharmacol Ther. 2002 Jan;16(1):119-27.

Sari et al. Impairment by lovastatin of neural relaxation of the rabbit sphincter of Oddi.
Eur J Pharmacol. 2001 Nov 30;432(1):91-7.

Roles of Vasoactive Intestinal Peptide (VIP) in the Expression of Different Immune Phenotypes by Wild-Type Mice and T Cell-Targeted Type II VIP Receptor Transgenic Mice.
The Journal of Immunology. 2003;170(1):308.